Free Trial

Artivion (AORT) Stock Price, News & Analysis

Artivion logo
$32.18 +1.60 (+5.23%)
Closing price 03:56 PM Eastern
Extended Trading
$32.16 -0.02 (-0.08%)
As of 06:12 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Artivion Stock (NYSE:AORT)

Key Stats

Today's Range
$30.48
$32.26
50-Day Range
$23.36
$31.17
52-Week Range
$21.97
$32.37
Volume
459,569 shs
Average Volume
338,146 shs
Market Capitalization
$1.37 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$32.40
Consensus Rating
Buy

Company Overview

Artivion Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
55th Percentile Overall Score

AORT MarketRank™: 

Artivion scored higher than 55% of companies evaluated by MarketBeat, and ranked 459th out of 921 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Artivion has received a consensus rating of Buy. The company's average rating score is 3.17, and is based on 5 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Artivion has only been the subject of 4 research reports in the past 90 days.

  • Read more about Artivion's stock forecast and price target.
  • Earnings Growth

    Earnings for Artivion are expected to grow by 35.14% in the coming year, from $0.37 to $0.50 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Artivion is -63.03, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Artivion is -63.03, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Artivion has a P/B Ratio of 4.78. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Artivion's valuation and earnings.
  • Percentage of Shares Shorted

    3.82% of the float of Artivion has been sold short.
  • Short Interest Ratio / Days to Cover

    Artivion has a short interest ratio ("days to cover") of 3.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Artivion has recently decreased by 3.80%, indicating that investor sentiment is improving.
  • Dividend Yield

    Artivion does not currently pay a dividend.

  • Dividend Growth

    Artivion does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    3.82% of the float of Artivion has been sold short.
  • Short Interest Ratio / Days to Cover

    Artivion has a short interest ratio ("days to cover") of 3.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Artivion has recently decreased by 3.80%, indicating that investor sentiment is improving.
  • News Sentiment

    Artivion has a news sentiment score of 1.70. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.57 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Artivion this week, compared to 3 articles on an average week.
  • Search Interest

    1 people have searched for AORT on MarketBeat in the last 30 days.
  • MarketBeat Follows

    1 people have added Artivion to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Artivion insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $2,108,525.00 in company stock.

  • Percentage Held by Insiders

    Only 8.10% of the stock of Artivion is held by insiders.

  • Percentage Held by Institutions

    86.37% of the stock of Artivion is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Artivion's insider trading history.
Receive AORT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Artivion and its competitors with MarketBeat's FREE daily newsletter.

AORT Stock News Headlines

I was wrong about Trump
I made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his advisors, I believed him. I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years. But I was wrong.
See More Headlines

AORT Stock Analysis - Frequently Asked Questions

Artivion's stock was trading at $28.59 on January 1st, 2025. Since then, AORT shares have increased by 10.2% and is now trading at $31.5050.

Artivion, Inc. (NYSE:AORT) posted its quarterly earnings data on Monday, May, 5th. The company reported $0.06 earnings per share for the quarter, missing analysts' consensus estimates of $0.12 by $0.06. The firm had revenue of $98.98 million for the quarter, compared to the consensus estimate of $94.81 million. Artivion had a negative net margin of 5.49% and a positive trailing twelve-month return on equity of 3.63%.
Read the conference call transcript
.

Shares of AORT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Artivion investors own include Humana (HUM), American Water Works (AWK), Voyager Therapeutics (VYGR), Waste Connections (WCN), The RMR Group (RMR), TotalEnergies (TTE) and Southern First Bancshares (SFST).

Company Calendar

Last Earnings
5/05/2025
Today
7/09/2025
Next Earnings (Estimated)
8/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
MED INSTRUMENTS
Sub-Industry
Medical Equipment
Current Symbol
NYSE:AORT
CIK
784199
Employees
1,600
Year Founded
N/A

Price Target and Rating

High Price Target
$35.00
Low Price Target
$30.00
Potential Upside/Downside
+0.7%
Consensus Rating
Buy
Rating Score (0-4)
3.17
Research Coverage
6 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
86.97
P/E Growth
N/A
Net Income
-$13.36 million
Pretax Margin
-5.79%

Debt

Sales & Book Value

Annual Sales
$388.54 million
Cash Flow
$0.89 per share
Price / Cash Flow
36.31
Book Value
$6.59 per share
Price / Book
4.88

Miscellaneous

Free Float
39,244,000
Market Cap
$1.37 billion
Optionable
Optionable
Beta
1.62
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (NYSE:AORT) was last updated on 7/9/2025 by MarketBeat.com Staff
From Our Partners